Curriculum Vitae

Gregory Reichard, Ph.D. 

Professional Experience: 15 years

Decision Informatics, Ltd.

President and Principal Consultant                                                    Oct. 2007 to present

University of Michigan                                                                                                

Adjunct Professor of Medicinal Chemistry                                       Nov. 2007 to present

 

Pfizer: 5 years

Senior Director, Lead Discovery                                                       Feb. 2006 to Oct. 2007

  • Built and led a multidisciplinary group of 31 scientists with the mission of discovering novel lead chemical series for the Ann Arbor (AA) Discovery portfolio.
  • Accountabilities, responsibilities and expertise:  novel series delivery; cross portfolio resource decisions; talent recruitment and development; effective outsourcing; frontier technology utilization; chemoinformatics and innovation in knowledge management.
  • Provide site-wide leadership as a member of the Chemistry Senior Staff, Chemistry Executive Leadership Team and the expanded Discovery Research Management Team.
  • Responsible for Pfizer’s global strategic direction of the Chemistry Discipline as a member of the Chemistry Discipline Leadership Team.
  • Recipient of the 2006 PGRD People Leader Award recognizing the top managers, globally, throughout PGRD for excellence in leadership.

Director, CNS Chemistry                                                                    Nov. 2003 to Jan. 2006

  • Led a group of 21 chemists working on multiple projects in the CNS therapeutic area.
  • Responsible for target selection, project prosecution and resource prioritization, tracking competitive activity, and therapeutic area strategy as a member and Chair of the AA CNS Management Team.
  • Responsible for strategic technology prioritization and technology partner line interfaces for the CNS therapeutic area.
  • Led a sustained effort to identify novel indications for established safe drug entities in the CNS area in partnership with the clinical line.
  • Responsible for strategic direction for the AA site as a member of the Discovery Management Forum.
  • Inspired excellence in the science of medicinal chemistry throughout the Ann Arbor Chemistry Department as a member of the AA Chemistry Senior Staff, with specific accountabilities for Chairing the Department Promotion Committee and helping to define clear roles and responsibilities for the performance evaluation process for the AA Chemistry Department.

Associate Research Fellow                                                               Aug. 2002 to Nov. 2003

  • Led a chemistry team of 8 scientists responsible for the delivery of drug candidates in the Inflammation therapeutic area.
  • Responsibilities: Project Leader for programs in rheumatoid arthritis and fibromyalgia.
  • Contributed to the development of TA strategy through the Inflammation New Projects team and the Discovery Fellows forum.
  • Partnered with PDM to institute an effective paradigm for rapid PK optimization.

Schering Plough Research Institute: 9 years

Section Leader                                                                                      Jan. 2001 to July 2002

  • Led a chemistry team of 4 Ph.D. scientists and 3 associate level scientists; responsible for developing chemistry team goals, prioritizing the efforts of our team in SAR studies and guiding our synthetic strategy in the effort to discover a development candidate for clinical studies.  
  • Lead chemist on the interdisciplinary Discovery Team, collaborating with scientists from Biology, Drug Metabolism / Pharmacokinetics, Discovery Formulations and Chemical Development.

Principal Scientist                                                                                July 1998 to Dec. 2000

  • Responsible for successfully leading a team of scientists in the discovery of a development candidate for clinical studies in the CNS area.  In this capacity, I supervised and scientifically contributed to the development of the SAR studies and appropriate synthetic routes necessary to identify and select this candidate.

Associate Principal Scientist                                                             Sept. 1995 to July 1998

  • Discovered a process for the synthesis of an optically pure fragment of a development candidate which was used by Chemical Development to ensure delivery of kilogram quantities for toxicological studies.
  • President’s Award for Discovery for work on “The Design, Synthesis and Characterization of Novel Dual NK1 / NK2 Antagonists”.

Senior Scientist                                                                                 Sept. 1993 to Sept. 1995

  • Discovered the first dual active oxime lead in the dual NK1 / NK2 antagonist project resulting in the delivery of a recommendation candidate for clinical studies.

Education

Harvard University                                                                           Sept. 1988 to Aug. 1993
Ph.D.                                                        

  • Research Advisor, Professor E. J. Corey
  • Dissertation: “The First Total Synthesis of Lactacystin”

The Ohio State University                                                              Sept. 1983 to June 1988
B.S. Summa Cum Laude with Honors
        in the Liberal Arts  and Distinction in Chemistry                      

  • Research Advisor, Professor J. S. Swenton
  • Thesis: “An Investigation of the Synthesis and Annelating Properties of Cyanophthalide Analogs of Indole